CORDIS · 609198 · FP7
SuperFlex Develop and demonstrate a ‘Mini-factory’ concept for production of personalized skin care products for elderly population
Coordinator: AHAVA DEAD SEA LABORATORIES LTD (IL)
Skin alterations within ageing are significant and visible, and therefore disturbing feature in the quality of life of aged people. Economic importance of this population is dramatically growing in Europe in the last decade. Regular skin care preparations are capable to cope with ageing symptoms to some extends, i.e. wrinkles, age spots and skin dryness, but limited in protecting skin from microbial contaminations, inflammation, irritation and other ageing related manifestations. A novel flexible customized skin care approach for better skin treatment is proposed by SuperFlex, combined with c…
About Seventh Framework Programme (2007–2013)
The Seventh Framework Programme (FP7) ran from 2007 to 2013 and was the EU's main research-funding instrument of that period. It mobilised roughly €50 billion across cooperation projects, ERC frontier grants, Marie Curie fellowships, capacity-building actions and Euratom research. FP7 closed to new calls in 2013 but its projects continued for years after under their original grant agreements.
EU contribution: €6.2M awarded to the consortium. The project runs over approximately 4 years from 2013-09-01 to 2017-08-31.
Full record on CORDIS — partners, deliverables, publications, news.
Open on cordis.europa.eu →More from IL
see all →- CloudCT — Climate CT- Cloud Tomography by Satellites for Better Climate Prediction810370 · H2020 · €13.9M
- LUCIA — Understanding Lung Cancer related risk factors and their Impact101096473 · HORIZON · €13.5M
- D2Smell — Digitising Smell: From Natural Statistics of Olfactory Perceptual Space to Digital Transmission of Odors101118977 · HORIZON · €11.8M
- SIIP — Speaker Identification Integrated Project607784 · FP7 · €10.5M
- SAVEME — A Modular Nanosystems Platform for Advanced Cancer Management: Nano-vehicles; Tumor Targeting and Penetration Agents; Molecular Imaging, Degradome based Therapy263307 · FP7 · €10.5M
- CATO — CATO - CBRN crisis management: Architecture, Technologies and Operational Procedures261693 · FP7 · €10.3M
Other FP7 projects
see all →- COST II — Provision of Scientific, Technical and Administrative Management of COST200443 · FR · €250.0M
- COMBACTE-NET — Combatting Bacterial Resistance in Europe115523 · SE · €109.4M
- EUC²LID — European Lead Factory115489 · DE · €80.0M
- COMBACTE-MAGNET — Combatting Bacterial Resistance in Europe - Molecules against Gram Negative Infections115737 · SE · €75.3M
- ENABLE — European Gram Negative Antibacterial Engine115583 · UK · €58.9M
- PLACES2BE — Pilot Lines for Advanced CMOS EmbodimentS in 2x nodes, Built in Europe325633 · FR · €52.6M
Frequently asked questions
- Who funds this research project?
- This project is funded by the European Union through the Seventh Framework Programme (2007–2013) programme, under the CP-TP funding scheme.
- What is the EU contribution?
- The European Commission contributes €6.2M.
- Which EU programme funds it?
- The project is funded under Seventh Framework Programme (2007–2013).
- Who coordinates the project?
- The project is coordinated by AHAVA DEAD SEA LABORATORIES LTD (IL).
- What is the project timeline?
- The project runs from 2013-09-01 to 2017-08-31 — approximately 4 years.
- Where can I find the full project record?
- The complete record — partners, deliverables, publications and news — is published on CORDIS under project ID 609198.